Urenco Isotopes provides the world with stable and medical isotopes for medical, research and industry uses.
Visit our Isotopes websiteSee what actions we are taking to achieve net zero by 2040 in our net zero transition plan.
Read it hereOur increased order book and solid financial and operational performance provide basis for future growth.
Read our latest report06 October 2021
In Urenco’s recent inclusion and diversity (I&D) survey, 45 colleagues (5%) identified as having a long-term condition or impairment.
We will be focussing on disabilities across all our sites as the main I&D theme for quarter four. Our quarterly I&D themes are intended to increase awareness, understanding and encourage conversations so we can learn together with the aim of minimising any stigma and accepting that we’re all different.
Not all disabilities are visible or immediately apparent, such as mental illness, chronic pain or fatigue, sight or hearing impairments, diabetes, brain injuries, neurological disorders, learning differences and cognitive dysfunctions, among others.
According to the WHO World Report on Disability, 15 per cent of the world’s population, or more than one billion people, are living with disability. Of this number, it’s estimated that 450 million are living with a mental or neurological condition - and two-thirds of these people will not seek professional medical help, largely due to stigma, discrimination and neglect.
This is something we are keen to better understand and ensure our employees are well supported and we are looking forward to a series of engaging and constructive interactions during the rest of the year.
Find out more about Urenco’s inclusion and diversity work in our:
Diversity and inclusion policy statement
About Urenco
Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.
With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries